Skye Bioscience SKYE Cash Flow Statement (2012-2026)

NASDAQ SKYE
$1.61 -0.01 (-0.60%)
As of: Oct 21, 2026 · 10:48 AM EDT
Reported Financials

Skye Bioscience Quarterly Cash Flow Statement

Periods 58 quarters
Latest Jun 2026

Skye Bioscience reported cash from operations of -$7.12M and free cash flow of -$7.12M for the quarter ended Jun 2026, up 33.7% year over year. This cash flow statement covers 58 quarters of results from Apr 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Dec2013 Apr2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.82M-2.51M-3.04M-3.42M-3.13M-9.89M-5.17M-3.11M-24.95M-4.42M-5.02M-7.90M-3.90M-9.75M-11.10M-17.62M-12.75M-14.44M-12.51M-10.79M
Depreciation and DepletionDep. & Depletion
0.01M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.05M0.03M0.03M0.07M0.08M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
420.000.15M0.15M444.00459.000.01M0.00M0.23M0.24M0.01M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.05M0.03M0.03M0.07M0.18M0.18M0.19M0.18M0.18M0.17M0.16M
Share-based CompensationStock Comp.
0.49M0.12M0.14M0.14M0.14M0.20M0.13M0.10M0.16M0.59M2.48M1.83M1.92M2.09M2.20M2.03M1.91M1.62M1.50M1.27M
Gains from Sales and DivestituresGains Divest
-0.31M1.15M0.07M0.14M0.09M0.09M0.18M-0.01M0.18M
Gains from Investment SecuritiesGains Investment
0.19M0.04M0.01M0.01M
Other non-cash itemsOther Non-Cash
0.02M-0.04M6.19M1.34M21.22M-0.16M8.79M0.17M1.00
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Account PayablesChange Payables
-0.09M0.61M0.02M0.08M0.27M0.32M-0.45M0.33M0.00M-0.46M-0.06M-0.02M-0.30M-0.21M1.22M1.37M-0.40M-0.79M1.90M0.34M
Change in Accured ExpensesChange Accured Exp.
0.15M0.08M-0.11M0.19M0.04M0.18M0.13M0.12M-0.27M0.24M-0.53M0.20M0.35M0.21M-0.46M0.21M0.05M0.35M-1.04M0.46M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
0.07M0.29M0.05M0.05M-0.13M-0.06M0.16M-0.44M-0.26M0.24M0.83M1.90M-0.64M-0.63M1.39M-1.81M2.62M-3.26M-0.24M-0.59M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.12M-0.13M0.00M-0.01M0.06M-1.87M-0.23M0.06M-0.56M0.06M0.07M0.09M0.91M-1.50M0.17M1.36M0.35M0.24M1.00M-2.81M
Other Working Capital ChangesOther WC Changes
-0.19M-0.41M-0.05M-0.07M0.19M-1.81M-0.39M0.50M-0.29M-0.18M-0.77M-1.82M1.55M-0.87M-1.22M3.17M-2.27M3.50M1.24M-2.22M
Cash from OperationsCash from Ops.
-1.49M-1.97M-2.91M-2.90M-2.06M-4.87M-4.06M-1.99M-4.05M-3.84M-4.71M-7.09M-5.26M-8.17M-9.19M-10.75M-13.36M-9.77M-8.56M-7.12M
Investing Activities
Capital ExpendituresCapex
0.03M0.05M0.00M0.08M0.37M-0.42M0.00M0.00M0.01M0.00M0.03M1.52M0.05M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
5.53M1.15M0.07M850.00
Change in Property, Plant and EquipmentChange in PP&E
-0.03M-0.05M0.00M-0.08M-0.37M0.42M5.53M0.00M-0.01M1.14M-0.03M-1.45M-0.05M-0.01M850.00
Acquisitions
-5.31M
Divestments
1.15M0.07M0.14M0.09M0.09M0.18M
Net of Acquisitions & DivestmentsNet Acquisitions
5.31M1.15M0.07M0.14M0.09M0.09M0.18M
Purchase of InvestmentsInvestments Purchased
12.80M11.94M-7.88M2.98M
Change in Acquisitions & DivestmentsChange Acquisitions
-12.80M-11.94M10.90M6.96M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.03M-0.05M0.00M-0.08M-0.37M5.67M5.53M1.07M-0.01M1.14M-0.03M-1.45M0.09M-12.81M-11.86M7.97M-2.80M10.90M7.14M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.07M0.11M
Non-Current Debt
-0.07M-0.11M
Short-Term Debt repaymentsST Debt Repayment
0.06M0.09M0.09M0.37M0.05M0.12M0.07M-0.24M
Current Debt
-0.06M-0.09M-0.09M-0.37M-0.05M-0.12M-0.07M0.24M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.06M-0.09M-0.09M-0.37M-0.05M-0.12M-0.07M0.24M-0.07M-0.11M
Change in Capital Stock
Common Stock IssuedStock Issued
13.07M0.00M0.00M11.73M-6.76M85.65M-2.10M-83.55M0.02M0.01M
Net Shares Issued and RepurchasedNet Shares Issued
13.07M0.00M0.00M11.73M-6.76M85.65M-2.10M-83.55M0.02M0.01M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
13.07M0.00M0.00M11.73M-6.76M85.65M-2.10M-83.55M0.02M0.01M
Cash from Financing ActivitiesCash from Financing
7.42M-0.08M-0.06M-0.09M-0.09M0.03M-0.05M-0.12M16.63M-0.02M85.65M-2.10M0.01M0.02M0.01M-0.07M-0.10M
Additional items
Change in Cash
5.90M-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M-0.08M
Ending Cash Balance
11.09M8.99M6.01M2.93M0.42M1.25M2.67M0.56M14.21M10.34M92.42M83.20M76.49M68.42M46.42M23.84M18.44M5.88M8.15M8.07M
Free Cash FlowFCF
-1.51M-2.02M-2.92M-2.99M-2.42M-4.45M-4.06M-1.99M-4.06M-3.85M-4.71M-7.13M-6.78M-8.22M-9.19M-10.75M-13.36M-9.77M-8.56M-7.12M
Net Cash FlowNCF
5.90M-2.11M-2.98M-3.08M-2.51M0.83M1.42M-2.12M13.65M-3.87M82.09M-9.22M-6.71M-8.08M-21.99M-22.58M-5.40M-12.56M2.27M-0.08M
Interest Paid
0.00M0.00M0.33M0.00M0.00M0.13M0.06M0.13M0.00M0.00M
Income Taxes PaidTaxes Paid
0.01M0.00M0.01M0.00M-0.01M0.00M0.00M0.00M0.00M

Skye Bioscience Cash Flow Statement API

Pull Skye Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SKYE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY